Since the pathogenic variants in TET2 were found across the risk groups of MDS, it is also likely that these variants could have been acquired by the mutant clones early in the pathogenesis of MDS, though the more deleterious variants like those leading to frameshift alterations were confined to the higher-risk groups. The gene discussed is TET2; the disease is myelodysplastic syndrome.